We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$49.3B
AUM Growth
+$3.1B
(+6.7%)
Cap. Flow
-$516M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
27.74%
Holding
1,796
New
24
Increased
581
Reduced
361
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$78.5M |
| 2 |
NVIDIA
NVDA
|
+$75.6M |
| 3 |
Eli Lilly
LLY
|
+$70.2M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$58.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$55.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$107M |
| 2 |
Pfizer
PFE
|
+$70M |
| 3 |
Johnson & Johnson
JNJ
|
+$68M |
| 4 |
Danaher
DHR
|
+$56.4M |
| 5 |
Walmart Inc
WMT
|
+$54.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.46% |
| 2 | Healthcare | 17.5% |
| 3 | Financials | 11.6% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.79T
| $3.12B | 6.33% |
16,090,151
+259,436
| +2% | +$45.2M |
|
|
2
Microsoft
MSFT
$2.9T
| $2.72B | 5.52% |
7,992,105
+250,586
| +3% | +$78.5M |
|
3
Amazon
AMZN
$2.63T
| $1.25B | 2.53% |
9,583,656
+217,652
| +2% | +$24.9M |
|
4
Alphabet (Google) Class A
GOOGL
$4.17T
| $1.23B | 2.5% |
10,310,810
-209,983
| -2% | -$24.2M |
|
|
5
NVIDIA
NVDA
$5.14T
| $1.19B | 2.42% |
28,196,920
+2,276,590
| +9% | +$75.6M |
|
6
UnitedHealth
UNH
$392B
| $983M | 1.99% |
2,045,262
-70,529
| -3% | -$34.5M |
|
|
7
Meta Platforms (Facebook)
META
$1.59T
| $971M | 1.97% |
3,382,926
+224,849
| +7% | +$55.5M |
|
8
Mastercard
MA
$470B
| $784M | 1.59% |
1,992,893
+37,013
| +2% | +$13.9M |
|
9
ExxonMobil
XOM
$640B
| $757M | 1.53% |
7,054,818
-312,853
| -4% | -$34.1M |
|
10
JPMorgan Chase
JPM
$926B
| $666M | 1.35% |
4,579,695
-171,905
| -4% | -$23.6M |
|
11
Tesla
TSLA
$1.4T
| $663M | 1.34% |
2,533,669
-93,654
| -4% | -$18.7M |
|
|
12
Johnson & Johnson
JNJ
$615B
| $659M | 1.34% |
3,982,744
-421,030
| -10% | -$68M |
|
|
13
Walmart Inc
WMT
$870B
| $633M | 1.28% |
12,072,660
-1,074,645
| -8% | -$54.2M |
|
14
Merck
MRK
$315B
| $609M | 1.23% |
5,275,496
-119,276
| -2% | -$13.5M |
|
15
Berkshire Hathaway Class B
BRK.B
$1.06T
| $511M | 1.04% |
1,499,262
-1,755
| -0.1% | -$573K |
|
16
Abbott
ABT
$175B
| $461M | 0.94% |
4,230,545
-102,517
| -2% | -$10.9M |
|
17
Procter & Gamble
PG
$347B
| $437M | 0.89% |
2,880,627
-178,409
| -6% | -$26.9M |
|
18
Thermo Fisher Scientific
TMO
$196B
| $413M | 0.84% |
790,779
+23,195
| +3% | +$12.5M |
|
|
19
Eli Lilly
LLY
$1.04T
| $411M | 0.83% |
876,385
+167,426
| +24% | +$70.2M |
|
20
Home Depot
HD
$330B
| $409M | 0.83% |
1,315,238
+166,947
| +15% | +$49.3M |
|
|
21
Alphabet (Google) Class C
GOOG
$4.17T
| $399M | 0.81% |
3,301,733
+27,360
| +0.8% | +$3.17M |
|
22
Applied Materials
AMAT
$440B
| $379M | 0.77% |
2,621,943
-129,177
| -5% | -$16.2M |
|
23
TJX Companies
TJX
$172B
| $373M | 0.76% |
4,403,437
+357,858
| +9% | +$28.2M |
|
24
ConocoPhillips
COP
$145B
| $365M | 0.74% |
3,519,574
-269,165
| -7% | -$27.7M |
|
25
Texas Instruments
TXN
$268B
| $359M | 0.73% |
1,993,588
-125,620
| -6% | -$21.6M |
|
Similar funds
SCP
Ensign Peak Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Ensign Peak Advisors held 1,796 positions worth $49.3B, up 6.7% from $46.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 3.3%. Ensign Peak Advisors opened 24 new positions and exited 35, leaving the 1,796-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q2 2023 buy was First Horizon: 875,834 shares worth $9.87M.
- Ensign Peak Advisors added most to Microsoft in Q2 2023, an estimated $78.5M increase.
- Ensign Peak Advisors's biggest Q2 2023 reduction was AbbVie, cutting an estimated $107M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $45M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $49.3B portfolio in Q2 2023.
- Ensign Peak Advisors opened 24 new positions and closed 35 in Q2 2023.
- Ensign Peak Advisors's portfolio value rose 6.7% quarter-over-quarter to $49.3B.
Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.